everolimus and sunitinib in pancreatic neuroendocrine tumors
Published 10 years ago • 887 plays • Length 4:38Download video MP4
Download video MP3
Similar videos
-
3:35
everolimus in pancreatic neuroendocrine tumors
-
4:39
using sunitinib in pancreatic neuroendocrine tumors (pnets)
-
5:52
everolimus in pancreatic neuroendocrine tumors and carcinoid tumors
-
3:33
radiant-3 trial: everolimus in pancreatic neuroendocrine tumors
-
2:01
dr. james yao on everolimus in advanced pancreatic neuroendocrine tumors
-
6:01
targeted therapies in pancreatic neuroendocrine tumors
-
5:43
targeted therapies for the treatment of nets
-
2:14
dr. james c. yao on everolimus in pancreatic neuroendocrine tumors
-
6:25
targeted treatment options for patients with neuroendocrine tumors
-
3:39
targeted therapies in neuroendocrine tumors
-
5:08
sunitinib versus placebo for patients with advanced unresectable pancreatic neuroendocrine tumors
-
7:08
sequencing considerations in advanced pancreatic neuroendocrine tumors
-
6:00
treatment sequencing and combinations in pancreatic neuroendocrine tumors
-
5:03
treating pancreatic neuroendocrine tumors
-
4:20
phase ii study of adjuvant everolimus on pancreatic neuroendocrine tumors of the liver
-
6:06
pancreatic neuroendocrine tumor diagnosis challenges
-
4:32
pathologic classification of neuroendocrine tumors
-
9:05
role of somatostatin analogs in pancreatic neuroendocrine tumors
-
3:14
everolimus for non-functional neuroendocrine tumours